IRSA Investments Holds On To 8% Gain Near Bell After Morgan Stanley Begins Coverage at Overweight April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Andrew Carideo IRSA Investments Holds On To 8% Gain Near Bell After Morgan Stanley Begins Coverage at Overweight.
